Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRR1 | P24046 | 5/20 | 0.36 |
| ▸ | SLC1A2 | P43004 | 3/20 | 0.33 |
| ▸ | GRM2 | Q14416 | 2/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | GRM8 | O00222 | 1/20 | 0.33 |
| ▸ | GRM6 | O15303 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | APEX1 | P27695 | 1/20 | 0.33 |
| ▸ | GRM5 | P41594 | 1/20 | 0.33 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.33 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.33 |
| ▸ | GRM3 | Q14832 | 1/20 | 0.33 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.32 |
| ▸ | GABRR2 | P28476 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3465515 | 1.00 | GABRR1 (0.36) | GABRR1SLC1A2GRM2CYP2C9CYP2C19 | |
| SCHEMBL13209239 | 1.00 | GABRR1 (0.36) | GABRR1SLC1A2GRM2CYP2C9CYP2C19 | |
| SCHEMBL3464490 | 1.00 | GABRR1 (0.36) | GABRR1SLC1A2GRM2CYP2C9CYP2C19 | |
| SCHEMBL2296098 | 1.00 | GABRR1 (0.36) | GABRR1SLC1A2GRM2CYP2C9CYP2C19 | |
| SCHEMBL3464832 | 1.00 | GABRR1 (0.36) | GABRR1SLC1A2GRM2CYP2C9CYP2C19 | |
| Hydrochloric Acid SCHEMBL949715 | 0.98 | GABRR1 (0.34) | GABRR1SLC1A2GRM2CYP2C9CYP2C19 | |
| SCHEMBL949713 | 0.83 | — | — | |
| SCHEMBL13795027 | 0.83 | — | — | |
| SCHEMBL17662660 | 0.81 | — | — | |
| SCHEMBL10958962 | 0.78 | KDM4E (0.43) | LMNAKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 92 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9718755-B2 | Methods for coproduction of terephthalic acid and styrene from ethylene oxide | NOVOMER, INC. (US) | 2017-08-01 | — | — | US | claimed |
| US-20170001939-A1 | METHODS FOR COPRODUCTION OF TEREPHTHALIC ACID AND STYRENE FROM ETHYLENE OXIDE | NOVOMER, INC. | 2017-01-05 | — | — | US | claimed |
| WO-2017004441-A2 | METHODS FOR COPRODUCTION OF TEREPHTHALIC ACID AND STYRENE FROM ETHYLENE OXIDE | Novomer, Inc (US) | 2017-01-05 | — | — | WO | claimed |
| EP-2054465-B1 | TAILORED CONTROL OF SURFACE PROPERTIES BY CHEMICAL MODIFICATION | ISIS INNOVATION (GB) | 2012-07-11 | — | — | EP | claimed |
| US-6677464-B2 | REACTING ALPHA, BETA-UNSATURATED CARBOXYLIC ACID WITH FURAN DERIVATIVE IN PRESENCE OF LEWIS ACID | KURARAY CO., LTD. (JP) | 2004-01-13 | — | — | US | claimed |
| US-20030187282-A1 | PROCESS FOR PREPARATION OF 7-OXABICYCLO[2.2.1]HEPT-5-ENE-2-CARBOXYLIC ACID DERIVATIVES | KURARAY CO., LTD. (JP) | 2003-10-02 | — | — | US | claimed |
| EP-1319662-A1 | PROCESS FOR PREPARATION OF 7-OXABICYCLO 2.2.1]HEPT-5-ENE-2-CARBOXYLIC ACID DERIVATIVES | Kuraray Co., Ltd. (JP) | 2003-06-18 | — | — | EP | claimed |
| US-20230167141-A1 | PSILOCIN DERIVATIVES AS SEROTONERGIC PSYCHEDELIC AGENTS FOR THE TREATMENT OF CNS DISORDERS | MINDSET PHARMA INC. (CA) | 2023-06-01 | — | — | US | disclosed |
| US-20220340893-A1 | BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES | NUEVOLUTION A/S (DK) | 2022-10-27 | — | — | US | disclosed |
| US-11225655-B2 | Bi-functional complexes and methods for making and using such complexes | NUEVOLUTION A/S (DK) | 2022-01-18 | — | — | US | disclosed |
| EP-3540059-A1 | BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES | Nuevolution A/S (DK) | 2019-09-18 | — | — | EP | disclosed |
| EP-2558577-B1 | BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES | NUEVOLUTION AS (DK) | 2018-12-12 | — | — | EP | disclosed |
| US-20180186807-A1 | COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN | BIOPHARMA CREDIT PLC (GB) | 2018-07-05 | — | — | US | disclosed |
| US-6291131-B1 | ADDITION POLYMERIZATION OF MONOMERS TO FORM PHOTORESISTS COPOLYMER | HYUNDAI ELECTRONICS INDUSTRIES CO., LTD. (KR) | 2001-09-18 | — | — | US | disclosed |
| US-5641784-A | ADENOSINE ANTAGONISTS; TREATMENT OF NERVOUS SYSTEM DISORDERS, ALZHEIMER'S DISEASE | BOEHRINGER INGELHEIM KG (DE) | 1997-06-24 | — | — | US | disclosed |
| EP-0593433-A1 | HERBICIDAL OXABICYCLO ETHERS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1994-04-27 | — | — | EP | disclosed |
| US-5234900-A | Herbicidal oxabicyclo ethers | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1993-08-10 | — | — | US | disclosed |
| EP-0487673-A1 | NEW XANTHINE DERIVATIVES | BOEHRINGER INGELHEIM INTERNATIONAL GmbH (DE) | 1992-06-03 | — | — | EP | disclosed |
| WO-1992000297-A1 | NEW XANTHINE DERIVATIVES | BOEHRINGER INGELHEIM KG (DE) | 1992-01-09 | — | — | WO | disclosed |
| WO-1991003464-A1 | HERBICIDAL OXABICYCLO ETHERS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-03-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030187282-A1 | PROCESS FOR PREPARATION OF 7-OXABICYCLO[2.2.1]HEPT-5-ENE-2-CARBOXYLIC ACID DERIVATIVES | ALOX5, ALOX15B, ALOX15 | GABRR1 3004/4885SLC1A2 2041/4885GRM2 992/4885 |
| US-20170001939-A1 | METHODS FOR COPRODUCTION OF TEREPHTHALIC ACID AND STYRENE FROM ETHYLENE OXIDE | FASN, CYP2E1, SCD | GABRR1 2089/4885SLC1A2 3121/4885GRM2 3440/4885 |
| US-20180186807-A1 | COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN | HBG2, HBG1, HBB | GABRR1 1979/4885SLC1A2 4475/4885GRM2 4536/4885 |
| US-20230167141-A1 | PSILOCIN DERIVATIVES AS SEROTONERGIC PSYCHEDELIC AGENTS FOR THE TREATMENT OF CNS DISORDERS | HTR1A, HTR6, HTR1B | GABRR1 1115/4885SLC1A2 100/4885GRM2 443/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.